Fibrinogen Concentrates Market : Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017-2021 and Forecast 2022-2028

$ PRICE - $ 3,000.00$ 8,900.00

Fibrinogen Concentrates Market: By Type (Human Fibrinogen Concentrates and Animal Fibrinogen Concentrates), By Application (Congenital Fibrinogen Deficiency and Surgical Procedures) and Geography (North America, Latin America, Europe, Asia Pacific, Middle East and Africa)

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Category:

Report

Description

The global fibrinogen concentrates market is estimated to be valued at around USD 2,644 million in 2021 and is poised to grow at a significant CAGR of 5.11% over 2022-2028. Due to the increase in the number of cases of bleeding disorders such as congenital afibrinogenemia, hypofibrinogenemia dysfibrinogenemia, low levels of fibrinogen could led to thrombosis, blood clot formation and others disorders. Fibrinogen Increasing in the R& D activities in biotechnology, increasing awareness, increasing medical infrastructure and rising government emphasis on the healthcare sector will fuel the market growth. However, high cost of fibrinogen concentrates test, lack of skilled medical professional and the concerns related with adverse effects such as nausea, vomiting, chills, dyspnea and arterial thrombosis  are the major factors that hinder the growth of the fibrinogen concentrates market.

Fibrinogen Concentrates Market

MARKET SUMMARY
-
5.11%
  • Study Period– 2021 – 2027
  • Base Year– 2020
  • CAGR– 5.11%
  • Largest Market– North-America
  • Fastest Growing Market– Asia Pacific

Fibrinogen Concentrates Market

  • Global fibrinogen concentrates market report gives comprehensive outlook on fibrinogen concentrates across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa.
  • The report gives historical, current, and future market sizes (US$ Mn) on the basis of product type, application, end user, and region.
  • Key stakeholders of the market report include suppliers, manufacturers, marketers, policy makers, and healthcare service providers engaged in global fibrinogen concentrates products.
Key Players
  • Baxter International Inc.
  • CSL Behring
  • LFB Group
  • ProFibrix BV
  • Shanghai RAAS
Fibrinogen Concentrates Market

In the recent years, Due to changing in the life styles and increased in the stress levels which leads to increase the number of many blood related disorders such as congenital afibrinogenemia, hypofibrogenemia, dysfibrinogenemia and others. Mainly, fibrinogen concentrates are utilized for the preparation of anti coagulates which is used to treat the above disorders. In addition, increasing expenditure on healthcare, growing awareness regarding the fibrinogen concentrates and rising biologic therapy, increasing drug development and Food and Drug Administration (FDA) approvals are estimated to boost market growth in near future.


North-America Got Significant Share

Fibrinogen Concentrates Market Regional Analysis

North America is predicted to have the largest share of the Nucleic Acid Amplification Testing market by 2027, and it is expected to grow at a rapid pace in the following years. Because of improved healthcare infrastructure and the increased prevalence of infectious diseases, the United States is predicted to be the largest nucleic acid amplification testing market. NAAT was deployed in Canada by the Canadian Blood Services, and it is helping to ensure a safer blood supply by detecting tiny quantities of viral genetic material.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Features of the Report

  • The Fibrinogen Concentrates Market report provides granular level information about the market size, regional market share, historic market (2017-2021), and forecast (2022-2028)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
Fibrinogen Concentrates Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

The Fibrinogen Concentrates Market is projected to expand at a CAGR of 5.11% during the forecast period.

Hualan Biological Engineering, Jiangxi Boya Bio-Pharmaceutical, LFB Group, ProFibrix BV, Shanghai RAAS

North America is dominating the Fibrinogen Concentrates Market


Report

Table Of Content

1. Executive Summary
2. Global Fibrinogen Concentrates Market Introduction
2.1. Global Fibrinogen Concentrates Market – Taxonomy
2.2. Global Fibrinogen Concentrates Market –Definitions
2.2.1. Indication Areas
2.2.2. End User
3. Global Fibrinogen Concentrates Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Fibrinogen Concentrates Market Dynamic Factors – Impact Analysis
3.6. Global Fibrinogen Concentrates Market – Competition Landscape
4. Global Fibrinogen Concentrates Market Analysis, 2017 – 2021 and Forecast, 2022- 2028
4.1. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Fibrinogen Concentrates Market, By Indication Areas, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
5.1. Afibrinogenemia and Hypofibrinogenemia
5.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Obstetric Hemorrhage
5.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
6. Global Fibrinogen Concentrates Market Forecast, By End User, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
6.1. Clinics
6.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Hospitals
6.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Others
6.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
7. Global Fibrinogen Concentrates Market Forecast, By Region, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
7.1. North America
7.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Europe
7.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Asia-Pacific
7.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Latin America
7.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
7.5. Middle East and Africa
7.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.5.3. Market Opportunity Analysis
7.6. Global Fibrinogen Concentrates Market – Opportunity Analysis Index, By Indication Areas, End User, and Region, 2022- 2028
8. North America Fibrinogen Concentrates Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
8.1. Indication Areas Analysis 2017 – 2021 and Forecast 2022- 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
8.1.1. Afibrinogenemia and Hypofibrinogenemia
8.1.2. Obstetric Haemorrhage
8.2. End User Analysis 2017 – 2021 and Forecast 2022- 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
8.2.1. Clinics
8.2.2. Hospitals
8.2.3. Others
8.3. Country Analysis 2017 – 2021 and Forecast 2022- 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
8.3.1. U.S.
8.3.2. Canada
8.4. North America Fibrinogen Concentrates Market – Opportunity Analysis Index, By Indication Areas, End User, and Country, 2022- 2028
8.5. North America Fibrinogen Concentrates Market Dynamics – Trends
9. Europe Fibrinogen Concentrates Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
9.1. Indication Areas Analysis 2017 – 2021 and Forecast 2022- 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.1.1. Afibrinogenemia and Hypofibrinogenemia
9.1.2. Obstetric Haemorrhage
9.2. End User Analysis 2017 – 2021 and Forecast 2022- 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.2.1. Clinics
9.2.2. Hospitals
9.2.3. Others
9.3. Country Analysis 2017 – 2021 and Forecast 2022- 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
9.3.1. Germany
9.3.2. UK
9.3.3. France
9.3.4. Spain
9.3.5. Italy
9.3.6. Rest of Europe
9.4. Europe Fibrinogen Concentrates Market – Opportunity Analysis Index, By Indication Areas, End User, and Country, 2022- 2028
9.5. Europe Fibrinogen Concentrates Market Dynamics – Trends
10. Asia-Pacific Fibrinogen Concentrates Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
10.1. Indication Areas Analysis 2017 – 2021 and Forecast 2022- 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Afibrinogenemia and Hypofibrinogenemia
10.1.2. Obstetric Haemorrhage
10.2. End User Analysis 2017 – 2021 and Forecast 2022- 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.2.1. Clinics
10.2.2. Hospitals
10.2.3. Others
10.3. Country Analysis 2017 – 2021 and Forecast 2022- 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.3.1. Japan
10.3.2. China
10.3.3. India
10.3.4. ASEAN
10.3.5. Australia & New Zealand
10.3.6. Rest of Asia-Pacific
10.4. Asia-Pacific Fibrinogen Concentrates Market – Opportunity Analysis Index, By Indication Areas, End User, and Country, 2022- 2028
10.5. Asia-Pacific Fibrinogen Concentrates Market Dynamics – Trends
11. Latin America Fibrinogen Concentrates Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
11.1. Indication Areas Analysis 2017 – 2021 and Forecast 2022- 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Afibrinogenemia and Hypofibrinogenemia
11.1.2. Obstetric Haemorrhage
11.2. End User Analysis 2017 – 2021 and Forecast 2022- 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.2.1. Clinics
11.2.2. Hospitals
11.2.3. Others
11.3. Country Analysis 2017 – 2021 and Forecast 2022- 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.3.1. Brazil
11.3.2. Mexico
11.3.3. Rest of Latin America
11.4. Latin America Fibrinogen Concentrates Market – Opportunity Analysis Index, By Indication Areas, End User, and Country, 2022- 2028
11.5. Latin America Fibrinogen Concentrates Market Dynamics – Trends
12. Middle East and Africa Fibrinogen Concentrates Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
12.1. Indication Areas Analysis 2017 – 2021 and Forecast 2022- 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Afibrinogenemia and Hypofibrinogenemia
12.1.2. Obstetric Haemorrhage
12.2. End User Analysis 2017 – 2021 and Forecast 2022- 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.2.1. Clinics
12.2.2. Hospitals
12.2.3. Others
12.3. Country Analysis 2017 – 2021 and Forecast 2022- 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.3.1. Gulf Cooperation Council (GCC) Countries
12.3.2. Israel
12.3.3. South Africa
12.3.4. Rest of MEA
12.4. MEA Fibrinogen Concentrates Market – Opportunity Analysis Index, By Indication Areas, End User, and Country, 2022- 2028
12.5. MEA Fibrinogen Concentrates Market Dynamics – Trends
13. Competition Landscape 
13.1. Strategic Dashboard of Top Market Players
13.2. Company Profiles (Introduction, Financial Analysis, Indication Areas & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
13.2.1. Octapharma
13.2.2. CSL Behring
13.2.3. Shanghai RAAS Blood Products Co., Ltd
13.2.4. LFB Biopharmaceuticals
13.2.5. Yoshitomi, Inc
13.2.6. LFB
13.2.7. Biotest AG
14. Research Methodology
15. Key Assumptions and Acronyms

 


Report

Company Profile

  • Baxter International Inc.
  • CSL Behring
  • Green Cross International
  • Harbin Pacific Biopharmaceutical Co. Ltd.
  • Hualan Biological Engineering
  • Jiangxi Boya Bio-Pharmaceutical
  • LFB Group
  • ProFibrix BV
  • Shanghai RAAS
  • Shanghai Xinxing Medicine Co. Ltd

Description

The global fibrinogen concentrates market is estimated to be valued at around USD 2,644 million in 2021 and is poised to grow at a significant CAGR of 5.11% over 2022-2028. Due to the increase in the number of cases of bleeding disorders such as congenital afibrinogenemia, hypofibrinogenemia dysfibrinogenemia, low levels of fibrinogen could led to thrombosis, blood clot formation and others disorders. Fibrinogen Increasing in the R& D activities in biotechnology, increasing awareness, increasing medical infrastructure and rising government emphasis on the healthcare sector will fuel the market growth. However, high cost of fibrinogen concentrates test, lack of skilled medical professional and the concerns related with adverse effects such as nausea, vomiting, chills, dyspnea and arterial thrombosis  are the major factors that hinder the growth of the fibrinogen concentrates market.

ASIA PACIFIC OFFICE

Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad - 500072

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX